Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide plus paclitaxel and carboplatin in advanced non-small cell lung cancer
CTR20132000Phase 2Completed
- Sponsor
- Akeso, Inc.
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in non-small cell lung cancer (NSCLC), sponsored by Akeso, Inc.. Started Apr 2014; status: completed.
02
Drugs
tucidinostat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20132000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132000.